These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6726805)

  • 21. New exfoliative toxin produced by a plasmid-carrying strain of Staphylococcus hyicus.
    Sato H; Watanabe T; Murata Y; Ohtake A; Nakamura M; Aizawa C; Saito H; Maehara N
    Infect Immun; 1999 Aug; 67(8):4014-8. PubMed ID: 10417168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth and analysis of crystal forms of toxic shock syndrome toxin 1.
    Earhart CA; Prasad GS; Murray DL; Novick RP; Schlievert PM; Ohlendorf DH
    Proteins; 1993 Nov; 17(3):329-34. PubMed ID: 8272430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of first exfoliative toxin in Staphylococcus pseudintermedius.
    Futagawa-Saito K; Makino S; Sunaga F; Kato Y; Sakurai-Komada N; Ba-Thein W; Fukuyasu T
    FEMS Microbiol Lett; 2009 Dec; 301(2):176-80. PubMed ID: 19891731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of the exfoliative toxin D gene in clinical Staphylococcus aureus isolates in France.
    Yamasaki O; Tristan A; Yamaguchi T; Sugai M; Lina G; Bes M; Vandenesch F; Etienne J
    Clin Microbiol Infect; 2006 Jun; 12(6):585-8. PubMed ID: 16700711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevalence of exfoliatin-producing strains in phage group II "Staphylococcus aureus" (author's transl)].
    Fleurette J; Ritter J
    Ann Microbiol (Paris); 1980; 131B(2):175-83. PubMed ID: 6450560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assays for epidermolytic toxin of Staphylococcus aureus.
    de Azavedo JC; Arbuthnott JP
    Methods Enzymol; 1988; 165():333-8. PubMed ID: 3148097
    [No Abstract]   [Full Text] [Related]  

  • 27. Nucleotide sequence of the epidermolytic toxin A gene of Staphylococcus aureus.
    O'Toole PW; Foster TJ
    J Bacteriol; 1987 Sep; 169(9):3910-5. PubMed ID: 3040667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Staphylococcus aureus exfoliatin toxin in staphylococcal infections in mice.
    Shibl AM
    Chemotherapy; 1981; 27(3):224-7. PubMed ID: 7226975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staphylococcal scalded skin syndrome related to an exfoliative toxin A- and B-producing strain in preterm infants.
    Rieger-Fackeldey E; Plano LR; Kramer A; Schulze A
    Eur J Pediatr; 2002 Dec; 161(12):649-52. PubMed ID: 12447663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exfoliative toxin production by Staphylococcus aureus strains isolated from animals and human beings in Nigeria.
    Adesiyun AA; Lenz W; Schaal KP
    Microbiologica; 1991 Oct; 14(4):357-62. PubMed ID: 1775093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel method for rapid production and purification of exfoliative toxin A of Staphylococcus aureus.
    Ladhani S; Cameron J; Chapple DS; Garratt RC; Joannou CL; Evans RW
    FEMS Microbiol Lett; 2002 Jun; 212(1):35-9. PubMed ID: 12076784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of exfoliative toxin A and B genes in Staphylococcus aureus isolated from clinical specimens.
    Koosha RZ; Fooladi AA; Hosseini HM; Aghdam EM
    J Infect Public Health; 2014; 7(3):177-85. PubMed ID: 24637043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and genetic characterization of PVL-positive ST8-MRSA-IVa and exfoliative toxin D-positive European CA-MRSA-Like ST1931 (CC80) MRSA-IVa strains in Bangladesh.
    Paul SK; Ghosh S; Kawaguchiya M; Urushibara N; Hossain MA; Ahmed S; Mahmud C; Jilani MS; Haq JA; Ahmed AA; Kobayashi N
    Microb Drug Resist; 2014 Aug; 20(4):325-36. PubMed ID: 24552553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of two serotypes of epidermolytic toxin from Staphylococcus aureus.
    Bailey CJ; de Azavedo J; Arbuthnott JP
    Biochim Biophys Acta; 1980 Jul; 624(1):111-20. PubMed ID: 6773585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purification, crystallization and preliminary X-ray analysis of toxic shock syndrome toxin-1 from Staphylococcus aureus.
    Passalacqua EF; Brehm RD; Acharya KR; Tranter HS
    J Mol Biol; 1992 Dec; 228(3):983-6. PubMed ID: 1469731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of epidermolytic toxin of Staphylococcus aureus.
    de Azavedo JC; Bailey CJ; Arbuthnott JP
    Methods Enzymol; 1988; 165():32-6. PubMed ID: 3231110
    [No Abstract]   [Full Text] [Related]  

  • 37. PCR investigation of Panton-Valentine leukocidin, enterotoxin, exfoliative toxin, and agr genes in Staphylococcus aureus strains isolated from psoriasis patients.
    Göçmen Jülide Sedef ; Sahiner N; Koçak M; Karahan ZC
    Turk J Med Sci; 2015; 45(6):1345-52. PubMed ID: 26775393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of staphylococcal enterotoxins, toxin genes and genetic-relatedness of foodborne Staphylococcus aureus strains isolated in the Marmara Region of Turkey.
    Aydin A; Sudagidan M; Muratoglu K
    Int J Food Microbiol; 2011 Aug; 148(2):99-106. PubMed ID: 21652103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between lesional or non lesional S. aureus strains from patients with impetigo and exfoliative toxin production. No association with SmaI PFGE patterns.
    Capoluongo E; Giglio A; Belardi M; Leonetti F; Frasca A; Giannetti A; Ameglio F
    New Microbiol; 2000 Jan; 23(1):21-7. PubMed ID: 10946402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico Analysis of Toxins of Staphylococcus aureus for Validating Putative Drug Targets.
    Mohana R; Venugopal S
    Infect Disord Drug Targets; 2017; 17(2):130-142. PubMed ID: 28034364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.